Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Ampronix

Events

11 May 2016 - 14 May 2016
16 May 2016 - 18 May 2016

Capnography Monitoring Solution Increases Patient Safety

By HospiMedica International staff writers
Posted on 31 Oct 2013
Print article
Image: The Capnostream 20p bedside monitor (Photo courtesy of Covidien).
Image: The Capnostream 20p bedside monitor (Photo courtesy of Covidien).
A new capnography solution offers enhanced features that could help clinicians identify and address serious respiratory care threats sooner.

The Capnostream 20p bedside monitor features the proprietary Apnea-Sat Alert algorithm, an algorithm that measures and reports recurring apnea and oxygen desaturation events, displaying the values directly on the Capnostream 20p monitor screen without requiring additional equipment or clinical workflow changes. Apnea-Sat Alert technology is also part of the broader family of Smart Alarm Management integrated algorithms that help to mitigate alarm fatigue, including Smart Breath Detection, a filter and pattern recognition algorithm that screens out low-amplitude “non-breath” etCO2 excursions like snoring, talking or crying, to provide a more accurate respiratory rate.

Other integrated algorithms include Smart Alarm for Respiratory Analysis (SARA), an alarm management technology that helps prevent alarm fatigue by reducing clinically insignificant respiratory alarms; Nellcor SatSeconds, a technology that helps analyze oxygen desaturation events; and the Integrated Pulmonary Index (IPI) algorithm that combines four respiratory measurements—capnography, respiratory rate, pulse rate, and pulse oximetry—to provide clinicians with an integrated snapshot of respiratory status.

The Capnostream 20p bedside monitor also includes the Microstream-enabled microMediCO2 module measurement bench, a module that offers easy integration into host monitor configurations, and is designed to support future Smart Capnography algorithms without requiring hardware upgrades. The Capnostream 20p bedside monitor is a product of Covidien (Dublin, Ireland), and has been approved by the US Food and drug Administration (FDA).

“Studies show that as many as 88% of hospitalized patients may be at risk for recurrent apneas, yet we’re only identifying and treating a very small number,” said Scott Kelley, MD, chief medical officer of respiratory and monitoring solutions at Covidien. “The Capnostream 20p bedside monitor will help increase apnea detection rates and represents an important advancement in continuous patient monitoring that we believe will help save lives.”

Related Links:

Covidien



Print article
Radcal
Barco

Channels

Women's Health

view channel

Suboptimal Weight Affects Survival in Cervical Cancer

Both overweight and underweight women with cervical cancer did not live as long as their normal-weight counterparts, according to a new study. Researchers at the University of Cincinnati (OH, USA) and the University of North Carolina (UNC; Chapel Hill, USA) conducted a retrospective cohort study of 623 women with cervical... Read more

Hospital News

view channel

Mikkeli Central Hospital to Undergo Major Modernization

The European Investment Bank (Luxemburg; EIB) has provided a long-term loan of € 55 million to the South Savo Social and Health Care Joint Authority to renovate and extend the Central Hospital campus in Mikkeli (Finland). The campus, situated in the center of the 55,000 municipality, will undergo a renovation and extension... Read more

Business

view channel

Mobility Aids Equipment Market to Experience Rapid Growth

The global market for mobility aids and transportation equipment market is estimated to reach USD 7.8 billion by 2021. These are the latest findings of IndustryARC (Hyderabad, India), an international research and consulting firm. Mobility equipment for the incapacitated, disabled and seniors is comprised of a large... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.